|
| ||
Home | Current Article | What is PXE? | Contact NAPE | Membership Form | PXE Pals | Q & A | Amsler Grid |
|
PXE Awareness |
|
Volume 13, Issue 2. July 2007 |
Atlanta Conference Presenters
Click to listen (2.2 MB)
Dr. Kenneth Neldner, Dermatologist, is a long term NAPE leader. His 1988 monograph described the first extensive PXE research. Clinics for Dermatology: Pseudoxanthoma Elasticum remains a basic text for researchers interested in PXE. Dr. Neldner will set the stage on Friday, preparing for more fruitful discoveries and understanding of Saturday’s program.
Dr. Berthold Struk, Cardiologist, Max-Delbruck Center for Molecular Medicine and Franz-Volhard Clinic for Cardiovascular Disease in Berlin, Germany, will present information about the impact of PXE on the cardiovascular system, basic care procedures to be followed by patients and their physicians, the inheritance of PXE and difficult treatment choices PXE patients may face.
Dr. Kattesh Katti, PhD, Department of Radiology, University of Mi
ssouri-Columbia, enjoys a worldwide reputation among scientists for his discoveries which have helped to usher in nanomedicine, as part of the nanotechnology revolution in science and industry. Dr. Katti, holder of such prestigious awards as the 2006 Gottingen Professorship and the St. Louis Academy of Science 2007 Scientist of the Year, will explain basic nanomedicine and how he has used it to diagnose and treat cancer and AMD.
Dr. Chris Bergstrom, Senior Retina Fellow, Emory Eye Center, Emory University, Atlanta, Georgia, will provide a research update on retinal treatments including vascular endothelial growth factor (VEGF) inhibitors such as Avastin, Lucentis and VEGF- Trap. He will also provide an update on stem cell research efforts related to the retina – both adult and embryonic.